Immunic, Inc.
NASDAQ:IMUXBiotechnology
Healthcare
$7.39 -0.28%
-$0.04 today
- Market cap
- $100.83M
- Beta
- 1.39
- P/E (TTM)
- -4.1
- EPS (TTM)
- -$3.46
52W Low $5.06High $15.77
Volume 0.39M
Average 0.27M
Balance Sheet
Inspect the capital base behind the business.
Assets
$24.05M
FY 2025 · Annual
-41.1% YoYLiabilities
$30.73M
FY 2025 · Annual
+36.9% YoYEquity
-$6.67M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 86.86M | 106.75M | 46.67M | 35.67M | 15.48M |
| Short-term Investments | 0 | 9.63M | 0 | 0 | 0 |
| Net Receivables | 2.15M | 296K | 703K | 684K | 4.12M |
| Inventory | 0 | 5.61M | 0 | 0 | 0 |
| Other Current Assets | 1.12M | 3.59M | 2.84M | 1.11M | 1.2M |
| Total Current Assets | 104.99M | 125.86M | 52.53M | 39.33M | 22.87M |
| Property, Plant & Equipment (Net) | 1.1M | 1.85M | 1.77M | 1.54M | 1.18M |
| Goodwill | 32.97M | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 42K | 43K | 0 | 0 | 0 |
| Total Non-current Assets | 34.11M | 1.89M | 1.77M | 1.54M | 1.18M |
| Total Assets | 139.1M | 127.75M | 54.3M | 40.87M | 24.05M |
| Account Payables | 3.5M | 4.28M | 5.1M | 7.85M | 10.14M |
| Short-term Debt | 0 | 0 | 0 | 0 | 470K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 851K | 7.34M | 17.48M | 676K | 20.01M |
| Total Current Liabilities | 11.4M | 13.08M | 24.73M | 22.18M | 30.62M |
| Long-term Debt | 0 | 0 | 0 | 0 | 107K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | (107K) |
| Total Non-current Liabilities | 584K | 992K | 639K | 264K | 107K |
| Total Liabilities | 11.99M | 14.07M | 25.37M | 22.44M | 30.73M |
| Common Stock | 3K | 4K | 4K | 8K | 9K |
| Retained Earnings | (196.87M) | (317.28M) | (410.89M) | (511.4M) | (608.57M) |
| Accumulated OCI | (252K) | 3.04M | 3.76M | 4.21M | 2.65M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 127.12M | 113.68M | 28.93M | 18.43M | (6.67M) |
| Total Debt | 992K | 1.56M | 1.33M | 1M | 684K |
| Net Debt | (85.87M) | (105.18M) | (45.34M) | (34.66M) | (14.8M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $186.6M |
| Receivables | $354.0K |
| Other Current | $1.8M |
| Total Current Assets | $188.8M |
| PP&E (Net) | $983.0K |
| Total Non-current Assets | $983.0K |
| Total Assets | $189.7M |
Analysis
Selected assets total $189.7M for Latest. The largest visible component is Cash & Equivalents at $186.6M, about 98.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 2, 2026 |
How much cash does IMUX have?
Immunic, Inc. (IMUX) reported $15.48M in cash and equivalents in fiscal 2025.
How much debt does IMUX carry?
Immunic, Inc. (IMUX) reported $684,000.00 of total debt, with net debt of -$14.80M.
Continue the stock analysis
Jump to another research area for this company.